USPTO 2015–2025 USPTO PatentsView US Corporation

Medtronic, Inc.

USPTO PatentsView assignee record — 3,184 granted patents across 124 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

3,184
Total patents granted
124
CPC technology areas
20.4
Avg claims per patent
-6%
5-year filing velocity

Portfolio overview

Medtronic, Inc. has been granted 3,184 US utility patents between 2015 and 2025, placing Medtronic, Inc. at rank #117 across all assignees tracked by PlainPatent. This portfolio spans 124 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.4 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Medtronic, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 72.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1,542 grants, compared with 1,642 in the 2015–2019 window — a -6% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medtronic, Inc.'s 20.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medtronic, Inc. against peers pursuing similar technology classes.

How does Medtronic compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Medtronic holds 3,184 patents — placing it at rank #117 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

150200250300350400 20152016201720182019202020212022202320242025 187
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medtronic, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 369 11.6%
2016 330 10.4%
2017 352 11.1%
2018 300 9.4%
2019 291 9.1%
2020 283 8.9%
2021 224 7.0%
2022 262 8.2%
2023 298 9.4%
2024 288 9.0%
2025 187 5.9%

Which technologies does Medtronic, Inc. patent most?

Top 15 of 124 technology areas

Patent Moat Analysis

Portfolio Volume Strong
Tech Breadth Diversified
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#117

Across all tracked assignees

Innovation Score

72.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medtronic, Inc. hold?
Medtronic, Inc. holds 3,184 US granted patents filed between 2015 and 2025, spanning 124 technology areas.
What is Medtronic, Inc.'s Innovation Score?
Medtronic, Inc. has an Innovation Score of 72.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medtronic, Inc. focus on?
Medtronic, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 2,200 patents. The company has filed patents in 124 CPC subclasses total.
Is Medtronic, Inc.'s patent filing rate increasing or decreasing?
Medtronic, Inc.'s recent filing velocity is -6% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Medtronic, Inc.'s patents?
Medtronic, Inc.'s patents average 20.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Medtronic, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope